glipizide

Generic: glipizide

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name glipizide
Generic Name glipizide
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

glipizide 10 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-105
Product ID 71610-105_cb4966b5-fc0b-416e-a3d3-9153957afd38
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075795
Listing Expiration 2026-12-31
Marketing Start 2002-09-25

Pharmacologic Class

Established (EPC)
sulfonylurea [epc]
Chemical Structure
sulfonylurea compounds [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610105
Hyphenated Format 71610-105

Supplemental Identifiers

RxCUI
310488
UNII
X7WDT95N5C
NUI
N0000175608 M0020795

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name glipizide (source: ndc)
Generic Name glipizide (source: ndc)
Application Number ANDA075795 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71610-105-53)
  • 90 TABLET in 1 BOTTLE (71610-105-60)
  • 120 TABLET in 1 BOTTLE (71610-105-70)
  • 180 TABLET in 1 BOTTLE (71610-105-80)
  • 270 TABLET in 1 BOTTLE (71610-105-92)
  • 360 TABLET in 1 BOTTLE (71610-105-94)
source: ndc

Packages (6)

71610-105-53 60 TABLET in 1 BOTTLE (71610-105-53) 71610-105-60 90 TABLET in 1 BOTTLE (71610-105-60) 71610-105-70 120 TABLET in 1 BOTTLE (71610-105-70) 71610-105-80 180 TABLET in 1 BOTTLE (71610-105-80) 71610-105-92 270 TABLET in 1 BOTTLE (71610-105-92) 71610-105-94 360 TABLET in 1 BOTTLE (71610-105-94)

Ingredients (1)

glipizide (10 mg/1)

Linked Drug Pages (1)

Glipizide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cb4966b5-fc0b-416e-a3d3-9153957afd38", "openfda": {"nui": ["N0000175608", "M0020795"], "unii": ["X7WDT95N5C"], "rxcui": ["310488"], "spl_set_id": ["9f7f880a-1060-431a-a155-884e8cfbdf22"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-105-53)", "package_ndc": "71610-105-53", "marketing_start_date": "20180727"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-105-60)", "package_ndc": "71610-105-60", "marketing_start_date": "20180727"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-105-70)", "package_ndc": "71610-105-70", "marketing_start_date": "20180727"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-105-80)", "package_ndc": "71610-105-80", "marketing_start_date": "20180727"}, {"sample": false, "description": "270 TABLET in 1 BOTTLE (71610-105-92)", "package_ndc": "71610-105-92", "marketing_start_date": "20180727"}, {"sample": false, "description": "360 TABLET in 1 BOTTLE (71610-105-94)", "package_ndc": "71610-105-94", "marketing_start_date": "20180815"}], "brand_name": "Glipizide", "product_id": "71610-105_cb4966b5-fc0b-416e-a3d3-9153957afd38", "dosage_form": "TABLET", "pharm_class": ["Sulfonylurea Compounds [CS]", "Sulfonylurea [EPC]"], "product_ndc": "71610-105", "generic_name": "Glipizide", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glipizide", "active_ingredients": [{"name": "GLIPIZIDE", "strength": "10 mg/1"}], "application_number": "ANDA075795", "marketing_category": "ANDA", "marketing_start_date": "20020925", "listing_expiration_date": "20261231"}